A Study of HMPL-523 in Patients With Relapsed or Refractory Mature B-cell Neoplasms (Q66395327)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Study of HMPL-523 in Patients With Relapsed or Refractory Mature B-cell Neoplasms |
clinical trial |
Statements
A Phase I, Open-label, Dose-escalation Study of the Safety and Pharmacokinetics of HMPL-523 in Patients With Relapsed or Refractory Mature B-cell Neoplasms (English)
0 references
27 December 2016
0 references
February 2021
0 references
217
0 references
18 year
0 references